Lexagene Holdings Inc
XTSX:LXG

Watchlist Manager
Lexagene Holdings Inc Logo
Lexagene Holdings Inc
XTSX:LXG
Watchlist
Price: 0.105 CAD Market Closed
Market Cap: 14.8m CAD
Section:
Relative Value
Relative Value
Valuation Multiples
Multiples Across Competitors
See Also

Relative Value

There is not enough data to reliably calculate the relative value of LXG.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

LXG Relative Value
Base Case
Not Available
Worst Case
Base Case
Best Case

Valuation Multiples

54.9
P/S
P/S
Price to Sales
54.9
vs History
vs Industry
Median 3Y
55.9
Median 5Y
56.2
Industry
2.4
Forward
2.2
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
Median 3Y
-0.7
Median 5Y
-0.7
Industry
22.4
More Details
Negative
P/OCF
P/OCF
Price to OCF
N/A
vs History
vs Industry
Median 3Y
-1.6
Median 5Y
-1.6
Industry
14.4
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
Median 3Y
-1.7
Median 5Y
-1.7
Industry
21.2
More Details
8.4
P/B
P/B
Price to Book Value
8.4
vs History
vs Industry
Median 3Y
8.5
Median 5Y
8.4
Industry
2.3
More Details
59.7
EV/S
EV/S
Enterprise Value to Sales
59.7
vs History
vs Industry
Median 3Y
60.7
Median 5Y
61
Industry
2.6
Forward
2.4
More Details
Negative
EV/GP
EV/GP
Enterprise Value to Gross Profit
N/A
vs History
vs Industry
Median 3Y
-12.5
Median 5Y
-12.8
Industry
5.3
More Details
Negative
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
N/A
vs History
vs Industry
Median 3Y
-0.7
Median 5Y
-0.8
Industry
12
More Details
Negative
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
N/A
vs History
vs Industry
Median 3Y
-0.7
Median 5Y
-0.7
Industry
16.6
More Details
Negative
EV/OCF
EV/OCF
Enterprise Value to OCF
N/A
vs History
vs Industry
Median 3Y
-1.7
Median 5Y
-1.7
Industry
14.6
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
Median 3Y
-1.7
Median 5Y
-1.7
Industry
18.3
More Details
4.1
EV/IC
EV/IC
Enterprise Value to IC
4.1
vs History
vs Industry
Median 3Y
4.2
Median 5Y
4.3
Industry
1.9
More Details

Multiples Across Competitors

LXG Competitors Multiples
Lexagene Holdings Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Lexagene Holdings Inc
XTSX:LXG
14.8m CAD 54.9 -0.6 -0.7 -0.7
US
Abbott Laboratories
NYSE:ABT
231.3B USD 5.4 16.5 21.8 30.8
US
Intuitive Surgical Inc
NASDAQ:ISRG
167.3B USD 18.3 64.2 49.9 59.9
US
Boston Scientific Corp
NYSE:BSX
158.7B USD 8.6 63.4 35.5 49
US
Stryker Corp
NYSE:SYK
149.9B USD 6.3 51.4 25.4 30.6
IE
Medtronic PLC
NYSE:MDT
119.1B USD 3.5 25.6 14 20.1
DE
Siemens Healthineers AG
XETRA:SHL
53B EUR 2.3 24.4 13.7 19.2
US
Becton Dickinson and Co
NYSE:BDX
55.1B USD 2.6 34.3 13.2 23.8
US
IDEXX Laboratories Inc
NASDAQ:IDXX
51.5B USD 12.8 52.3 37.6 41.7
US
Edwards Lifesciences Corp
NYSE:EW
47.4B USD 8.3 11.4 25.3 27.8
CN
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
288.5B CNY 8.8 31.4 27.4 27.4

See Also

Summary
LXG intrinsic value, competitors valuation, and company profile.
DCF Valuation
LXG stock valuation using Discount Cash Flow valuation method.
Relative Valuation
LXG stock valuation using valuation multiples.
Wall Street Estimates
LXG price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
LXG stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 280,400+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.